Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Peter, Klemets"'
Autor:
Anu Kantele, Marianna Riekkinen, T Sakari Jokiranta, Sari H Pakkanen, Jukka-Pekka Pietilä, Anu Patjas, Mari Eriksson, Tamim Khawaja, Peter Klemets, Kati Marttinen, Heli Siikamäki, Anna Lundgren, Jan Holmgren, Agneta Lissmats, Nils Carlin, Ann-Mari Svennerholm
Publikováno v:
Journal of Travel Medicine.
Background No licensed human vaccines are available against enterotoxigenic Escherichia coli (ETEC), a major diarrhoeal pathogen affecting children in low- and middle-income countries and foreign travellers alike. ETVAX®, a multivalent oral whole-ce
Publikováno v:
Journal of Evaluation in Clinical Practice. 20:333-341
Rationale, aims and objectives Invasive pneumococcal diseases (IPD) are associated with substantial burden in adults (≥50 years). Moreover, adults with vascular, metabolic or respiratory diseases have been shown to have a 3–6 times higher risk of
Autor:
J. Pekka Nuorti, Sandra Guedes, Jussi Sane, Eija Kela, Satu Kurkela, Peter Klemets, Olli Vapalahti, Outi Lyytikäinen, Jukka Ollgren
Publikováno v:
The Journal of Infectious Diseases. 204:459-466
Background. Sindbis virus (SINV) is an arthropod-borne alphavirus that causes rash and arthritis. In Finland, epidemics occur cyclically, but factors associated with clinical SINV infection are largely unknown. We conducted a population-based case-co
Autor:
Agostinho Marques, Luis Salleras, David S. Fedson, Mark van der Linden, Laurence Nicolas-Spony, Peter Klemets, Sandrine I. Samson
Publikováno v:
Expert Review of Vaccines. 10:1143-1167
Vaccination is the only public-health measure likely to reduce the burden of pneumococcal diseases. In 2010, a group of European experts reviewed evidence on the burden of pneumococcal disease and the immunogenicity, clinical effectiveness and cost-e
Autor:
Jukka Ollgren, Petri Ruutu, Outi Lyytikäinen, Peter Klemets, Maija Leinonen, J. Pekka Nuorti, Tarja Kaijalainen
Publikováno v:
Scandinavian Journal of Infectious Diseases. 40:621-628
We evaluated regional variation and trends in invasive pneumococcal infections (IPI) in Finland by using data from national, population-based laboratory surveillance and number of blood and cerebrospinal fluid (CSF) cultures performed by all microbio
Autor:
Peter Klemets, Outi Lyytikäinen, Janne Aittoniemi, J. Pekka Nuorti, Vesa Lindström, Jukka Ollgren, Marjatta Sinisalo, Raija Silvennoinen
Publikováno v:
Infectious diseases (London, England). 48(5)
The baseline national invasive pneumococcal disease (IPD) incidence rate, serotype distribution and serotype coverage of pneumococcal vaccines were evaluated in patients with Hodgkin's and non-Hodgkin's lymphomas, myeloma and leukaemia within 1 year
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 8, Iss 1, p 96 (2008)
BMC Infectious Diseases, Vol 8, Iss 1, p 96 (2008)
Background The 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended for persons aged < 65 years with chronic medical conditions. We evaluated the risk and mortality from invasive pneumococcal disease (IPD) among persons with and witho
Autor:
Kalervo Werkkala, Matti Valtonen, Veli-Jukka Anttila, Kaisa Huotari, Anne M. Eklund, Outi Lyytikäinen, Peter Klemets
Publikováno v:
The Annals of thoracic surgery. 82(5)
Poststernotomy mediastinitis as a complication is rare but disastrous. We assessed incidence, predisposing factors for, and outcome from, mediastinitis after cardiac surgery.We studied 10,713 consecutive patients who underwent open-heart surgery from
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 118(4)
Autor:
Lindström, Vesa1 (AUTHOR) vesa.lindstrom@hus.fi, Aittoniemi, Janne2 (AUTHOR), Lyytikäinen, Outi3 (AUTHOR), Klemets, Peter4 (AUTHOR), Ollgren, Jukka3 (AUTHOR), Silvennoinen, Raija5 (AUTHOR), Nuorti, J. Pekka3,6 (AUTHOR), Sinisalo, Marjatta7 (AUTHOR)
Publikováno v:
Infectious Diseases. May2016, Vol. 48 Issue 5, p399-402. 4p. 1 Chart, 2 Graphs.